RhumbLine Advisers’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $498K | Buy |
|
|||||
|
2025
Q1 | $146K | Sell |
|
|||||
|
2024
Q4 | $175K | Buy |
|
|||||
|
2024
Q3 | $275K | Buy |
|
|||||
|
2024
Q2 | $191K | Buy |
|
|||||
|
2024
Q1 | – | Hold |
|
|||||
|
2023
Q4 | – | Hold |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $146 | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $86K | Sell |
|
|||||
|
2021
Q4 | $138K | Buy |
|
|||||
|
2021
Q3 | $178K | Buy |
|
|||||
|
2021
Q2 | $267K | Buy |
|
|||||
|
2021
Q1 | $194K | Buy |
|
|||||
|
2020
Q4 | $265K | Buy |
|
|||||
|
2020
Q3 | $58K | Sell |
|
|||||
|
2020
Q2 | $104K | Buy |
|
|||||
|
2020
Q1 | $64K | Buy |
|
|||||
|
2019
Q4 | $115K | Buy |
|
|||||
|
2019
Q3 | $247K | Buy |
|
|||||
|
2019
Q2 | $114K | Buy |
|
|||||
|
2019
Q1 | $140K | Sell |
|
|||||
|
2018
Q4 | $419K | Buy |
|
|||||
|
2018
Q3 | $468K | Buy |
|
|||||
|
2018
Q2 | $306K | Buy |
|